EGS Leaders Chart the Future of Glaucoma Care

• by Julian Upton

• June 23, 2026

Phacoemulsification with goniosynechialysis for nanophthalmos with secondary angle-closure or secondary angle-closure glaucoma: a 20-case series and stepwise management strategy

• by Hongyan Zhu, Zuohong Wu, Yong Wang, Xun Zhan, Jin Lv, Li Ye

• June 1, 2026

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

• by Andrea Surnit

• July 8, 2026

• 3 min

Two-year outcomes of trabeculo-canalectomy for glaucoma secondary to iridocorneal endothelial syndrome: a retrospective study

• by Zhan Xie, Haiyue Xie, Yangyang Lu, YingTing Zhu, Ping Xie, Hong Sun

• July 15, 2026